tirzepatide trial results of the phase 3b TOGETHER-PsA showed ixekizumab administered together with in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight Cardiovascular Outcomes with Tirzepatide versus
Pay in 4 interest-free payments of $5.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



























